References

Haimeur, A. and O. Marc, 1988. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate. Antimicrob. Agents Chemother., 42: 1689-1694.

Jha, T.K., P. Olliaro, C.P.N. Thakur, T.P. Kanyok and B.L. Singhania et al., 1998. Randomized controlled trial of aminosidine (paromomycin) Vs sodium stiboglu-conate for treating visceral leishmaniasis in North Bihar, India. Br. Med. J, 316: 1200-1205.
PubMed  |  

Kanyok, T.P., A.D. Killian, K.A. Rodvold and L.H. Danziger, 1997. Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects. Antimicrob. Agents Chemother., 41: 982-986.
PubMed  |  

Khalil, E.A.G., A.M. El-Hassan, E.E. Zijlstra, M.M. Muktar and H.W. Ghalib et al., 2000. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomized, double-blind, BCG-controlled trial in Sudan. Lancet, 356: 1565-1569.

Kitchen, I., 1984. Cardiac and Vascular Preparations: Textbook of In vitro Practical Pharmacology. Blackwell Scientific Publications, Great Britain, pp: 101-118.

Kitchen, I., 1984. Isolated Small Intestine: Textbook of in vitro Practical Pharmacology. Blackwell Scientific Publications, Great Britain, pp: 101-118.

Kitchen, I., 1984. Isolated Uterus: Textbook of in vitro Practical Pharmacology. Blackwell Scientific Publications, Great Britain, pp: 33-39.

Philip, D.H., 2001. Important Drug Interactions and Their Mechanism. In: Basic and Clinical Pharmacology, Katzung, B.G. (Ed.). 8th Edn., McGraw-Hill, New York, pp: 1122-1133.

Philippe, J.G., O. Piero, S. Shyam, B. Marleen and L.C. Simon et al., 2002. Visceral leishmaniasis: Current status and development agenda. Lancet Infect. Dis., 2: 494-501.

Ponte-Sucre, A., 2003. Physiological consequences of drug resistance in leishmania and their relevance for chemotherapy. Kinetoplastid Biol. Dis., 2: 1-8.

Scott, J.A.G., R.N. Davidson, A.H. Moody, H.R. Grant and D. Felmingham et al., 1992. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the united kingdom. Trans. R. Soc. Trop. Med. Hyg., 86: 617-619.

Sorin, E.L. and V. Laurinan, 2006. Pharmacokinetics and metabolic drug interactions. Curr. Clin. Pharmacol., 1: 5-20.

Thakur, C.P., T.P. Kanyok, A.K. Pandey, G.P. Sinha and A.E. Zaniewski et al., 2000. A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg., 94: 429-431.

Tracy, J.W. and L.T. Webster, 2001. Drugs Used in the Chemotherapy of Protozoal Infections. In: Good-man and Gilman's the Pharmacological Basis of Therapeutics, Joel, G.H. and L.E. Limbird (Eds.). 10th Edn., McGraw Hill, New York, USA., pp: 1097-1120.